SCHEMBL17599409

SCHEMBL17599409

Cc1cc(C)c(C)c(S(=O)(=O)Nc2c(Br)cc(-c3cccc(C(=O)OC(C)(C)C)c3)c3ccccc23)c1C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 2/20 0.38
▸ KMT2A Q03164 2/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ CRHBP P24387 1/20 0.38
▸ CRHR2 Q13324 1/20 0.38
▸ HSD17B10 Q99714 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ ABCG2 Q9UNQ0 2/20 0.36
▸ ABCB1 P08183 1/20 0.36
▸ STAT3 P40763 1/20 0.36
▸ LMNA P02545 1/20 0.34
▸ GAA P10253 1/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ HTT P42858 1/20 0.34
▸ SLC7A5 Q01650 1/20 0.34
▸ CA12 O43570 2/20 0.34
▸ CA1 P00915 2/20 0.34
▸ CA2 P00918 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17599380 0.85 MEN1 (0.44) MEN1KMT2AKDM4EALDH1A1HPGD
SCHEMBL17599366 0.83 KDM4E (0.41) MEN1KMT2AKDM4EALDH1A1HPGD
SCHEMBL17599321 0.83 MCL1 (0.35) MEN1KMT2AKDM4EALDH1A1HPGD
SCHEMBL17599308 0.80 FAAH (0.34) MEN1KMT2AKDM4EALDH1A1HPGD
SCHEMBL17599410 0.76 ABCG2 (0.35) ABCG2ABCB1STAT3SLC7A5CA12
SCHEMBL17613340 0.75 SLC7A5 (0.42) ABCG2ABCB1STAT3SLC7A5CA12
SCHEMBL17599386 0.73 MEN1 (0.37) MEN1KMT2AKDM4EALDH1A1HPGD
SCHEMBL17599346 0.72 CDC25B (0.45) MEN1KMT2AKDM4EALDH1A1HPGD
SCHEMBL17599329 0.70 KMT2A (0.55) MEN1KMT2AKDM4EALDH1A1HPGD
SCHEMBL17613335 0.69 ABCG2 (0.37) SMN1; SMN2ABCG2ABCB1STAT3SLC7A5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2998294-A1 Naphthyl sulfonamide phenyl derivatives as KEAP-1 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders SANOFI (FR) 2016-03-23 — — EP disclosed
EP-2998294-A1 Naphthyl sulfonamide phenyl derivatives as KEAP-1 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders SANOFI (FR) 2016-03-23 — — EP disclosed
Send feedback